サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1338878

心臓マーカー検査市場、シェア、規模、動向、産業分析レポート：製品タイプ別、エンドユーザー別、地域別、セグメント別予測、2023～2032年

Cardiac Marker Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Reagents and Kits and Instruments); By Biomarker Type; By End-User; By Region; Segment Forecast, 2023-2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
心臓マーカー検査市場、シェア、規模、動向、産業分析レポート：製品タイプ別、エンドユーザー別、地域別、セグメント別予測、2023～2032年
出版日: 2023年06月23日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の心臓マーカー検査市場規模は2032年までに97億3,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

救急部（ED）における心血管疾患患者数の世界の急増、POCTのような複数の心臓バイオマーカー検査に対する需要の高まりと採用は、世界市場の成長を促進する顕著な要因です。さらに、新規参入企業は最大限の収益を上げるために継続的に検査市場に参入しており、既存参入企業は研究開発活動に投資することでポートフォリオの開拓と拡大に注力しています。例えば、2023年1月、Cipla社は、糖尿病、感染症、甲状腺機能、炎症、代謝マーカーの検査を提供するCE IVD承認のポイントオブケア検査機器である「Cippoint」という新しい検査機器を発表しました。

さらに、心臓マーカーにおける最近の進歩は、市販の機器から、心筋トロポニンやナトリウム利尿ペプチドなどの新技術や、1回のアッセイで多数の分子標的を通して多重化を可能にすることで、特異性と信頼性を向上させたPoint-Of-Careイムノアッセイにまで及んでいます。ミレニアル世代における不健康な食品の消費量の増加により狭心症の患者数が増加しており、このような患者層からの急増する需要に対応するため、心臓バイオマーカーの採用が急速に増加します。

がん疾患やその他の様々な疾患の有病率が大幅に増加し、各国政府はヘルスケアシステムの開発や高度な心臓マーカー検査機器へのアクセスに向けて時間と資金を重点的に投資しています。例えば、米国心臓病学会（American College of Cardiology）が行った新しい調査によると、研究者は、ApoB検査が、LDLコレステロール値が正常でなくても心血管リスクが高い可能性のある患者の特定に役立つ可能性があることを発見しました。

心臓マーカー検査市場レポートハイライト

2022年の世界市場シェアは、心臓バイオマーカー検査の採用増加により、試薬・キット分野が大半を占める

トロポニンIおよびTセグメントは、主に急性心筋梗塞を診断するためのこれらの機器に対する需要の増加により、2022年に大きな市場収益シェアを占めました。

ポイントオブケア施設分野は、主要ヘルスケアサービスプロバイダーでの利用拡大により、調査期間中最も高いCAGRで成長すると予測されます。

北米地域は2022年に世界市場を独占したが、これはヘルスケアインフラへの支出が多いことと、米国やカナダなどの国々で先進的な心臓バイオマーカーが迅速に採用されていることによる。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の心臓マーカー検査市場の洞察

  • 心臓マーカー検査市場- バイオマーカーの種類のスナップショット
  • 心臓マーカー検査市場力学
    • 促進要因と機会
      • 心血管疾患の発生率の上昇
      • 高度な技術の進歩
    • 抑制要因と課題
      • サンプルの収集と保管に関する技術的問題
  • PESTEL分析
  • 心臓マーカー検査市場のバイオマーカーの種類の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の心臓マーカー検査市場、製品別

  • 主な調査結果
  • イントロダクション
  • 試薬とキット
  • 装置

第6章 世界の心臓マーカー検査市場、用途別

  • 主な調査結果
  • イントロダクション
  • 臨床検査施設
  • ポイントオブケア検査施設
  • 学術機関

第7章 世界の心臓マーカー検査市場、バイオマーカータイプ別

  • 主な調査結果
  • イントロダクション
  • トロポニンIとT
  • クレアチンキナーゼ-MB（CK-MB）
  • ナトリウム利尿ペプチド
  • ミオグロビン
  • 高感度C反応性タンパク質
  • その他の心臓バイオマーカー

第8章 世界の心臓マーカー検査市場、地域別

  • 主な調査結果
  • イントロダクション
    • 心臓マーカー検査市場評価、地域別、2019～2032年
  • 心臓マーカー検査市場-北米
    • 北米：心臓マーカー検査市場、製品別、2019～2032年
    • 北米：心臓マーカー検査市場、バイオマーカータイプ別、2019～2032年
    • 北米：心臓マーカー検査市場、用途別、2019～2032年
    • 心臓マーカー検査市場-米国
    • 心臓マーカー検査市場- カナダ
  • 心臓マーカー検査市場- 欧州
    • 欧州：心臓マーカー検査市場、製品別、2019～2032年
    • 欧州：心臓マーカー検査市場、バイオマーカータイプ別、2019～2032年
    • 欧州：心臓マーカー検査市場、用途別、2019～2032年
    • 心臓マーカー検査市場- 英国
    • 心臓マーカー検査市場- フランス
    • 心臓マーカー検査市場- ドイツ
    • 心臓マーカー検査市場- イタリア
    • 心臓マーカー検査市場- スペイン
    • 心臓マーカー検査市場- オランダ
    • 心臓マーカー検査市場- ロシア
  • 心臓マーカー検査市場- アジア太平洋
    • アジア太平洋：心臓マーカー検査市場、製品別、2019～2032年
    • アジア太平洋：心臓マーカー検査市場、バイオマーカータイプ別、2019～2032年
    • アジア太平洋：心臓マーカー検査市場、用途別、2019～2032年
    • 心臓マーカー検査市場- 中国
    • 心臓マーカー検査市場- インド
    • 心臓マーカー検査市場- マレーシア
    • 心臓マーカー検査市場- 日本
    • 心臓マーカー検査市場- インドネシア
    • 心臓マーカー検査市場- 韓国
  • 心臓マーカー検査市場-中東およびアフリカ
    • 中東およびアフリカ：心臓マーカー検査市場、製品別、2019～2032年
    • 中東およびアフリカ：心臓マーカー検査市場、バイオマーカータイプ別、2019～2032年
    • 中東およびアフリカ：心臓マーカー検査市場、用途別、2019～2032年
    • 心臓マーカー検査市場- サウジアラビア
    • 心臓マーカー検査市場- アラブ首長国連邦
    • 心臓マーカー検査市場- イスラエル
    • 心臓マーカー検査市場- 南アフリカ
  • 心臓マーカー検査市場-ラテンアメリカ
    • ラテンアメリカ：心臓マーカー検査市場、製品別、2019～2032年
    • ラテンアメリカ：心臓マーカー検査市場、バイオマーカータイプ別、2019～2032年
    • ラテンアメリカ：心臓マーカー検査市場、用途別、2019～2032年
    • 心臓マーカー検査市場- メキシコ
    • 心臓マーカー検査市場- ブラジル
    • 心臓マーカー検査市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers
  • Becton Dickson
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • LSI Medience
  • Quidel Corporation
  • Randox Laboratories
  • PerkinElmer
  • Tosoh Corporation
  • Alfa Scientific Designs
  • Response Biomedical
  • Creative Diagnostics
図表

List of Tables

  • Table 1 Global Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 4 Cardiac Marker Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 6 North America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 8 U.S.: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 9 U.S.: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 11 Canada: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 12 Canada: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 14 Europe: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 15 Europe: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 17 UK: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 18 UK: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 20 France: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 21 France: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 26 Italy: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Italy: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 29 Spain: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 30 Spain: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 35 Russia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Russia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 41 China: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 42 China: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 44 India: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 45 India: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 50 Japan: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Japan: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 56 South Korea: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 57 South Korea: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 65 UAE: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 66 UAE: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 68 Israel: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 69 Israel: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 71 South Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 72 South Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 74 Latin America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 75 Latin America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 77 Mexico: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 78 Mexico: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 80 Brazil: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 81 Brazil: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 83 Argentina: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Argentina: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cardiac Marker Testing Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Cardiac Marker Testing Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Cardiac Marker Testing Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Biomarker Type
  • Figure 11. Global Cardiac Marker Testing Market, by Biomarker Type, 2022 & 2032 (USD Billion)
  • Figure 12. Cardiac Marker Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Cardiac Marker Testing Market
目次
Product Code: PM3322

The global cardiac marker testing market size is expected to reach USD 9.73 billion by 2032, according to a new study by Polaris Market Research. The report "Cardiac Marker Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Reagents and Kits and Instruments); By Biomarker Type; By End-User; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rapid increase in the number of cardiovascular disease patients globally in the emergency departments (EDs), the rising demand and adoption for several cardio biomarkers test like POCT, are prominent factors propelling the global market growth. Moreover, new players are continuously entering into the market with tests in order to generate maximum revenues and established players are focusing on developing and expanding their portfolio by investing in R&D activities, that are further anticipated to create growth opportunities. For instance, in January 2023, Cipla, introduced its new testing devices named 'Cippoint', a CE IVD-approved point-of-care testing device that offers testing for diabetes, infectious diseases, thyroid function, inflammation, and metabolic markers.

Moreover, the recent advances in the cardiac markers from the commercial devices to emerging technologies such as cardiac troponin and natriuretic peptides and Point-Of-Care immunoassays with improved specificity and reliability by enabling the multiplexing through the numerous molecular targets in single assays. The rising consumption of several types of unhealthy food products among millennials resulting in high number of angina pectoris cases, thus to cater the surging demand from these patient pool, adoption of cardiac biomarkers will increase rapidly.

With the drastic increase in the prevalence for cancer diseases and various other disorders and governments are heavily investing their time and money towards the development of their healthcare systems and access to advanced cardiac markers testing devices. For instance, according to a new study done by American College of Cardiology, researchers found that ApoB testing might help in the identification of patients who may still be at the high risk of cardiovascular without having normal LDL cholesterol levels.

Cardiac Marker Testing Market Report Highlights

Reagents and kits segment accounted for major global market share in 2022, on account on increasing adoption of the cardiac biomarker tests

Troponin I and T segment held the significant market revenue share in 2022, mainly due increasing demand for these devices to diagnose acute myocardial infraction

Point-of-care facilities segment is projected to grow at a highest CAGR over the study period, that is highly attributable to its growing utilization among major healthcare service providers

North America region dominated the global market in 2022, owing to high spending on healthcare infrastructure and quick adoption of advanced cardiac biomarkers in countries like US and Canada

The global key market players include: Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Medtronic PLC; Stryker Corporation; Zimmer-Biomet Holdings, Inc.; DePuy Synthes; Smith and Nephew PLC; Aesculap Implant Systems, LLC; Conmed Corporation; Donjoy, Inc.; NuVasive, Inc. and Roche

Polaris Market Research has segmented the cardiac marker testing market report based on product, biomarker type, end-user, and region:

Cardiac Marker Testing, Product Outlook (Revenue - USD Billion, 2018 - 2030)

  • Reagents and Kits
  • Instruments

Cardiac Marker Testing, Biomarker Type Outlook (Revenue - USD Billion, 2018 - 2030)

  • Troponin I and T
  • Creatine Kinase-MB (CK-MB)
  • Natriuretic Peptide
  • Myoglobin
  • High Sensitivity C-Reactive Protein
  • Other Cardiac Biomarkers

Cardiac Marker Testing, End-User Outlook (Revenue - USD Billion, 2018 - 2030)

  • Laboratory Testing Facilities
  • Point-Of-Care Testing Facilities
  • Academic Institutions

Cardiac Marker Testing, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cardiac Marker Testing Market Insights

  • 4.1. Cardiac Marker Testing Market - Biomarker Type Snapshot
  • 4.2. Cardiac Marker Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of cardiovascular diseases
      • 4.2.1.2. High technological advancements
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Technical issues related to sample collection and storage
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cardiac Marker Testing Market Biomarker Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cardiac Marker Testing Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Reagents and Kits
    • 5.3.1. Global Cardiac Marker Testing Market, by Reagents and Kits, by Region, 2019-2032 (USD Billion)
  • 5.4. Instruments
    • 5.4.1. Global Cardiac Marker Testing Market, by Instruments, by Region, 2019-2032 (USD Billion)

6. Global Cardiac Marker Testing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Laboratory Testing Facilities
    • 6.3.1. Global Cardiac Marker Testing Market, by Laboratory Testing Facilities, by Region, 2019-2032 (USD Billion)
  • 6.4. Point-Of-Care Testing Facilities
    • 6.4.1. Global Cardiac Marker Testing Market, by Point-Of-Care Testing Facilities, by Region, 2019-2032 (USD Billion)
  • 6.5. Academic Institutions
    • 6.5.1. Global Cardiac Marker Testing Market, by Academic Institutions, by Region, 2019-2032 (USD Billion)

7. Global Cardiac Marker Testing Market, by Biomarker Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • 7.3. Troponin I and T
    • 7.3.1. Global Cardiac Marker Testing Market, by Troponin I and T, By Region, 2019-2032 (USD Billion)
  • 7.4. Creatine Kinase-MB (CK-MB)
    • 7.4.1. Global Cardiac Marker Testing Market, by Creatine Kinase-MB (CK-MB), By Region, 2019-2032 (USD Billion)
  • 7.5. Natriuretic Peptide
    • 7.5.1. Global Cardiac Marker Testing Market, by Natriuretic Peptide, By Region, 2019-2032 (USD Billion)
  • 7.6. Myoglobin
    • 7.6.1. Global Cardiac Marker Testing Market, by Myoglobin, By Region, 2019-2032 (USD Billion)
  • 7.7. High-Sensitivity C-Reactive Protein
    • 7.7.1. Global Cardiac Marker Testing Market, by High-Sensitivity C-Reactive Protein, By Region, 2019-2032 (USD Billion)
  • 7.8. Other Cardiac Biomarkers
    • 7.8.1. Global Cardiac Marker Testing Market, by Other Cardiac Biomarkers, By Region, 2019-2032 (USD Billion)

8. Global Cardiac Marker Testing Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cardiac Marker Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cardiac Marker Testing Market - North America
    • 8.3.1. North America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Cardiac Marker Testing Market - U.S.
      • 8.3.4.1. U.S.: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Cardiac Marker Testing Market - Canada
      • 8.3.5.1. Canada: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Cardiac Marker Testing Market - Europe
    • 8.4.1. Europe: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Cardiac Marker Testing Market - UK
      • 8.4.4.1. UK: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Cardiac Marker Testing Market - France
      • 8.4.5.1. France: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Cardiac Marker Testing Market - Germany
      • 8.4.6.1. Germany: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Cardiac Marker Testing Market - Italy
      • 8.4.7.1. Italy: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Cardiac Marker Testing Market - Spain
      • 8.4.8.1. Spain: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Cardiac Marker Testing Market - Netherlands
      • 8.4.9.1. Netherlands: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Cardiac Marker Testing Market - Russia
      • 8.4.10.1. Russia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Cardiac Marker Testing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Cardiac Marker Testing Market - China
      • 8.5.4.1. China: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Cardiac Marker Testing Market - India
      • 8.5.5.1. India: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Cardiac Marker Testing Market - Malaysia
      • 8.5.6.1. Malaysia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Cardiac Marker Testing Market - Japan
      • 8.5.7.1. Japan: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Cardiac Marker Testing Market - Indonesia
      • 8.5.8.1. Indonesia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Cardiac Marker Testing Market - South Korea
      • 8.5.9.1. South Korea: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Cardiac Marker Testing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Cardiac Marker Testing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Cardiac Marker Testing Market - UAE
      • 8.6.5.1. UAE: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Cardiac Marker Testing Market - Israel
      • 8.6.6.1. Israel: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Cardiac Marker Testing Market - South Africa
      • 8.6.7.1. South Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Cardiac Marker Testing Market - Latin America
    • 8.7.1. Latin America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Cardiac Marker Testing Market - Mexico
      • 8.7.4.1. Mexico: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Cardiac Marker Testing Market - Brazil
      • 8.7.5.1. Brazil: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Cardiac Marker Testing Market - Argentina
      • 8.7.6.1. Argentina: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. F. Hoffmann-La Roche AG
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Abbott Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Danaher Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Siemens Healthineers
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Becton Dickson
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Bio-Rad Laboratories
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Thermo Fisher Scientific
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. LSI Medience
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Quidel Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Randox Laboratories
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. PerkinElmer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Tosoh Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Alfa Scientific Designs
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Response Biomedical
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Creative Diagnostics
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development